Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Stem Cell Therapy for Fracture Non-union
NCT02177565Completed
- Sponsor
- The Robert Jones and Agnes Hunt Orthopaedic Hospital
- Start
- Jan 2000
- Primary completion
- Oct 2011
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Randomised, double-blind trial of autologous bone marrow derived mesenchymal stromal cells in fracture nonunion (2 arms), sponsored by The Robert Jones and Agnes Hunt Orthopaedic Hospital. Primary endpoint: Radiological assessment of new callus and fracture bridging at 12 months. Started Jan 2000; status: completed.
02
Drugs
autologous bone marrow derived mesenchymal stromal cells
03
Conditions
fracture nonunion
Beyond the preview
Go deeper on NCT02177565.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02177565.